Publications by authors named "Adrian Langleben"

Claim this Profile
T
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLC.
Jhanelle E Gray, Michael Schenker, Mehmet Ali Nahit Şendur, Viktoriya Leonova, Dariusz Kowalski, Adrian Langleben

J Thorac Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
Yohann Pilon, Merav Rokah, Joseph Seitlinger, Boris Sepesi, Roni F Rayes, Adrian Langleben

Clin Lung Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line Therapy.
Karen Gambaro, Maud Marques, Suzan McNamara, Mathilde Couetoux du Tertre, Cyrla Hoffert, Adrian Langleben

Int J Mol Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study.
Michael Boyer, Mehmet A N Şendur, Delvys Rodríguez-Abreu, Keunchil Park, Dae Ho Lee, Adrian Langleben

J Clin Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reasons for delay in timely administration of adjuvant chemotherapy for patients with stage III colon cancer: a multicentre cohort study from the McGill University Department of Oncology.
Arielle Elkrief, Genevieve Redstone, Luca Petruccelli, Alla'a Ali, Doneal Thomas, Adrian Langleben

BMJ Open Qual· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.
Cristiano Ferrario, Ivan Strepponi, Khashayar Esfahani, Helen Charamis, Adrian Langleben

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer.
Fleur Huang, Yael B Kushner, Adrian Langleben, William D Foulkes

Nat Rev Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic cranial irradiation in advanced breast cancer: a case for caution.
Fleur Huang, Munir Alrefae, Adrian Langleben, David Roberge

Int J Radiat Oncol Biol Phys· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term use of antihypertensive drugs and risk of cancer.
Themistocles L Assimes, Eleanor Elstein, Adrian Langleben, Samy Suissa

Pharmacoepidemiol Drug Saf· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
Tejas Sankar, Zografos Caramanos, Rachid Assina, Jean-Guy Villemure, Richard Leblanc, Adrian Langleben

J Neurooncol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An oncology perspective on the benefits and cost of combined androgen blockade in advanced prostate cancer.
Armen G Aprikian, Neil Fleshner, Adrian Langleben, Jeffrey Hames

Can J Urol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trial.
Vera Hirsh, Renaud Whittom, Linda Ofiara, Pierre Desjardins, Joseph Ayoub, Adrian Langleben

Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring informed consent in an oncology study posing serious risk to subjects.
Myrian Skrutkowski, Charles Weijer, Stan Shapiro, Abraham Fuks, Adrian Langleben

IRB· March 2000

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis